Toshimi Usui
Impact in
-
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Carcinogens and Genotoxicity Assessment 6
- Oncology 9
- Cancer-related Molecular Pathways 6
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Hiroshi MasudaCarl L. AldenDaniel MortonArthur RothMamoru MutaiShigeru HisadaB. D. McCulloughKeith A. Soper
- Journals
- Toxicologic Pathology (5 papers)EXPERIMENTAL ANIMALS (3 papers)Toxicology (1 paper)Chemotherapy (1 paper)Reproduction (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Toshimi Usui
27 papers receiving 354 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 137
- Chemical Health and Safety 4
- Small Animals 37
- Pharmacology 30
- Oncology 88
Countries citing papers authored by Toshimi Usui
This map shows the geographic impact of Toshimi Usui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshimi Usui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshimi Usui more than expected).
Fields of papers citing papers by Toshimi Usui
This network shows the impact of papers produced by Toshimi Usui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshimi Usui. The network helps show where Toshimi Usui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toshimi Usui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 5 | |
| 2 | 2006 | 8 | |
| 3 | 2003 | 21 | |
| 4 | 2002 | 3 | |
| 5 | 2001 | 6 | |
| 6 | 2001 | 74 | |
| 7 | 2000 | 8 | |
| 8 | TESTING HUMAN PHARMACEUTICALS FOR CARCINOGENIC POTENTIAL : NEW APPROACH IN ICH PROCESS | 1998 | 3 |
| 9 | 1996 | 54 | |
| 10 | 1993 | 3 | |
| 11 | 1992 | 4 | |
| 12 | 1991 | 14 | |
| 13 | 1990 | 9 | |
| 14 | Toxicological studies of imipenem/cilastatin sodium (i): Acute toxicity studies in mice and rats | 1985 | 1 |
| 15 | 1979 | 4 | |
| 16 | THIRTY-MONTH CHRONIC TOXICITY STUDIES WITH METHYL MERCURY CHLORIDE IN RATS (The 5th Meeting for the Study of Toxic Effect) | 1978 | 1 |
| 17 | 1974 | 0 | |
| 18 | Oral toxicity studies of disodium 5'-ribonucleotide in the rat | 1971 | 1 |
| 19 | 1967 | 28 | |
| 20 | 1962 | 9 |
About Toshimi Usui
Toshimi Usui is a scholar working on Cancer Research, Oncology, Biotechnology, Pharmacology and Molecular Biology, having authored 30 papers that have together received 385 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (6 papers), Cancer-related Molecular Pathways (6 papers), Virus-based gene therapy research (3 papers), Cancer Research and Treatments (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Renal and related cancers (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). The work is most often cited by research in Cancer Research (137 citations), Chemical Health and Safety (4 citations), Small Animals (37 citations), Pharmacology (30 citations) and Oncology (88 citations). Toshimi Usui has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hiroshi Masuda, Carl L. Alden, Daniel Morton, Arthur Roth, Mamoru Mutai, Shigeru Hisada, B. D. McCullough, Keith A. Soper, Hiroyuki Mima and Hiroshi Kuno. Their work appears in journals such as Toxicologic Pathology, EXPERIMENTAL ANIMALS, Toxicology, Chemotherapy and Reproduction.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.